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1. Introduction 
Although the function of tRNA and the role of 
specific regions of the various tRNA molecules in 
protein synthesis have been studied intensively, rela- 
tively little progress has been made in this field. Thus, 
the anticodons of valine [l] , tyrosine [2] and for- 
mylmethionine [3] tRNA’s have been established by 
direct experiments. However, attempts to locate the 
aminoacyl tRNA synthetase recognition sites have 
not been successful. It has been shown that the ter- 
minal sequence C-C-A,, is indispensable for amino- 
acylation [4] but the role of other regions of the 
tRNA molecule remained rather ambiguous. The 
anticodon, most probably, has no significance in the 
recognition of aminoacyl tRNA synthetase [ 1,3,5-71. 
In 1967 we have reported data on the enzymatic 
aminoacylation of tRNAYa’ halves [8] and on the 
functional topography of tRNA by using the “dis- 
sected molecule” method. Here we describe the re- 
sults of further investigations on aminoacylation of 
valine tRNA fragments. 
2. Methods 
tRNAya’ fragments were prepared by partial 
digestion of tRNAyal 3’- and 5’- halves with guanylo- 
RNase (EC 2.7.7.26) from Actinomyces aureoverti- 
ciZIatus Kras et Di Shen and pancreatic pyrimidyle 
RNase (EC 2.7.7.16). The fragments were isolated and 
purified by ion exchange chromatography on a DEAE- 
cellulose column at pH 8.0 and pH 3.3 in 7M urea 
191 f 
268 
The fragments were identified by the method pre- 
viously described [9] or by two dimensional thin 
layer cellulose chromatography of complete quanylo- 
or pyrimidylo-RNase digests of the fragments. The 
assay mixture for the estimation of acceptor activity 
of tRNAya’ fragments contained the following com- 
ponents @moles) in a total volume of 0.5 ml: Tris-HCl 
buffer, pH 7.5,50; MgCl, 10; KC1 10; EDTA 1; 
ATP 5; C14-labelled valine (specific activity 105 
&/pmole) 1; partially purified yeast aminoacyl tRNA 
synthetase 0.2 mg (protein); and specified amounts 
of tRNAya’ fragments. 
tRNAIVal fragments were dissolved in water and 
after the addition of all the components except the 
enzyme the mixture was preincubated at 15” for 
20 min. After addition of the enzyme the mixture was 
incubated for 30 min at 15”. The reaction was stopped 
with the addition of 0.5 mg of Cetavlon (cetyltrime- 
thylammonium bromide) dissolved in 0.1 ml of 
0.75 M phosphate buffer, pH 5.0. The precipitate was 
collected on a microcellulose filter, washed with 50 ml 
of 0.03% Cetavlon solution, dried and counted in a 
scintillation counter with 50-60% efficiency. 
3. Results 
The primary structure of tRNAyal has been 
established earlier [lo] . Bayev et al. [8] have found 
that the halves of tRNAy” obtained after the cleavage 
of the phosphodiester bond between Ij5 and Aj6 in 
the anticodon region did not possess the ability to 
be aminoacylated and did not inhibit the enzymatic 
aminoacylation of the intact tRNAra’ either. Never- 
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Table 1 
Acceptor activity of tRNAyal fragments. Incubation mixture (see Methods) contained tRNAplO.09 Az60 unit, 5’- or 3’-half 
0.05 Azao unit, and fragments 0.03 A ~~0 unit each. Halves and other shorter fragments of tRNAp’ are denoted by H and F res- 
pectively. Indices at H and F represent he original numbers o e corresponding nucleotides beginning from the 5’ end of the 
tRN Af’molecule. 
tRNAy”I fragments 
14C-va.line incorporation 
Halves : Fragments c.p.m. 
1 tRNAy* 14500 
2 H1-35 + H3617 14500 
3 Hl- 32 + H3617 13800 
4 H1-35 + H41-77 33 
5 H1e3s + H41J17 + A-C-A-C-Gp 400 
6 HI-35 + F41k7 171 
7 H1-35 + F5817 208 
8 H1-35 + F36+3 99 
9 H1-3, + F36+7 879 
lo H3677 + Fw-3s 198 
11 H1-35 + F41--57 + Fsa-77 151 
12 H1-35 + F36--57 + F58-17 14925 
13 H1-3s + F36--53 +Fs877 5080 
theless, upon mixing the two halves form an aggregate 
exhibiting an acceptor activity equal to-.that of intact 
tRNAVal. Data concerning the acceptor activity of 
tRNA t al fragments other than the halves described 
above are summarized in table 1. 
We suppose that the restoration of acceptor activity 
is preceded by the self-assembly of the fragments in 
the aggregate tRNA molecules. Two kinds of aggre- 
gate molecules can be distinguished: (1) those with 
one or more split phosphodiester bonds (dissected 
molecules), (2) aggregate molecules lacking some part 
of the polynucleotide chain (incomplete molecules). 
The incomplete aggregate molecule, with excised 
trinucleotide $33-U-Ip in the anticodon region, as 
shown in fig. 1, exhibits the same acceptor activity as 
a dissected molecule formed by the two halves (table 
1, exp. 3). 
The dissected aggregate molecule with two split 
phosphodiester bonds at I35 and G57 exhibits full 
acceptor activity. A more incomplete molecule, 
devoid of the ubiquitous tetranucleotide sequence 
T54--$-C-G,, has only 35% activity (table 1, exp. 
12 and 13). The incomplete aggregate molecule, de- 
void of the pentanucleotide A36--C-A-C-G,, is 
fully inactive when composed of two or of three frag- 
ments (table 1, exp. 4 and 11). The activity is not 
restored if the pentanucleotide A36-C-A-C-Gp is 
added to the incubation mixture (table 1, exp. 5). 
Other fragment combinations shown in table 1 are 
also inactive (exp. 5-10). 
The results of the functional study of tRNA7 
fragments are summarized in fig. 1. tRNAra’ is pre- 
sented in the clover leaf model with two split inter- 
nucleotide bonds. However, we do not assume this to 
be the real shape of tRNAy aggregated molecules. 
4. Discussion 
The removal of three nucleotides $35-U-Ip from 
the seven constituting the anticodon loop of tRNAy 
(No. 33-39), including the first anticodon nucleotide 
I,, , does not impair the acceptor activity of the mole- 
cule. There is some evidence that the other nticleotides 
Volume 3, number 4 FEBS LETTERS June 1969 
9 
Rou 
Fig. 1. Acceptor activity of dissected tRNA?l molecules. 
@ aminoacylation;Ono aminoacylation; ‘cleavage of phoe 
phodiester bond; c7 eliminated sequences. 
of the anticodon loop are also not necessary for the 
interaction between tRNA and aminoacyl tRNA syn- 
thetase. The excision of 9 in tRNAFt& [ 1 l] as well 
as the modification of tRNA$& [7], located in posi- 
tions, corresponding to the 38th and 39th nucleotides 
of tRNAya’ does not impair the acceptor activity 
either. 
The inactivation observed after the removal of the 
pentanucleotide A36-C-A-C-G, is due possibly to 
the lack of the guanylic acid residue G40. The latter 
may be a component of the recognition site or it is in- 
dispensable for the stability of the conformation of 
the anticodon branch which seems to be of importance 
for the acceptor activity of the whole molecule. 
The elimination of the ubiquitous tetranucleotide 
sequence T54-J/-C-G, does not inactivate tTNAr’. 
It has been shown, however, that the 3’-half, which 
contains the tetranucleotide as a component, is bound 
to the 50s ribosomal sub-unit [S] . One can assume 
that the tetranucleotide T,g-$-C-G, does not parti- 
cipate in the tRNA - aminoacyl-tRNA-synthetase 
interaction but it is necessary for binding with the 
SOS ribosomal sub-unit. 
The results of these investigations have been re- 
ported at the 6th FEBS Meeting (Madrid, 1969) [ 121. 
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